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HANS TORMA AND ANDERS VAHLQUIST, M.D. 
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Since the origin of 3-dehydroretinol in epidermis is 
unknown, we have investigated the possible conversion 
of all-trans-retinol to 3-dehydroretinol by organ cul-
tured keratome slices (0.3 mm) of human breast skin. 
[ 3 H]Retinol bound to retinol-binding protein (RBP) was 
incubated for 24 h with the tissue sample, which was 
then extracted and analyzed by high-performance liquid 
chromatography. Radioactive material that comigrated 
with authentic 3-dehydroretinol was purified to homo-
geneity. The identity of this material was established by 
treatment with HCl which resulted in a typical forma-
. tion of the anhydro form of 3-dehydroretinol. 
3 -[3 H]Dehydroretinol could not be detected in the in-
cubation medium and was not found in the skin when 
the sample was heat-inactivated before incubation. The 
tissue production of 3-[3 H]dehydroretinol from [3 H]ret-
inol continued when the tracer was removed from the 
medium, attaining a maximum value of 25% of the ret-
inol value at 50 h. It is suggested that epidermal 3-
dehydroretinol in vivo originates from serum retinol 
delivered to the keratinocytes by RBP. 
Vitamin A2 (3-dehydroretinol)* is a normal constituent of 
human epidermis amounting to about 20% of the vitamin A1 
(retinol) concentration [1). Negligible amounts of 3-dehydro-
retinol are found in other human tissues and it has not been 
detected in blood plasma [2]. For reasons as yet unknown, the 
epidermal concentration of 3-dehydroretinol (but not retinol) 
increases up to 10-fold in some pathologic conditions of the 
skin (e.g., psoriasis, Darier's disease, and basal cell carcinoma) 
(3- 6). 
The origin of 3-dehydroretinol in human epidermis has been 
an enigma, but the avai lable evidence suggests that it is pro-
duced locally [7] . Putative precursors are retinol and certain 
t issue carotenoids. For example, the carotenoid anhydrolutein 
is converted to 3-dehydroretinol when fed to fish and chicks 
[8,9]. Retinol has been implicated as a precursor of 3-dehydro-
retinol in the eye of amphibians t hat utilize 3-dehydroretinal-
dehyde as visual pigment (10,11]. 
The delivery of retinol to keratinocytes and other epithelial 
cells involves a serum retinol-binding protein (RBP) which 
binds to a cell -surface receptor [12,13). Using an organ culture 
system originally devised for studies of [aH]retinol uptake from 
RBP to human epidermis [12], we have now demonstrated for 
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Abbreviations: 
HPLC: high-performance liquid chromatography 
RBP: retinol-binding protein 
* 3-Dehydroreti nol is synonymous to 3,4-didehydroretinol or dehy-
droretinol. 
the first time that retinol is converted to 3-dehydroretinol in 
the skin, thus establishing a new pathway for vitamin A me-
tabolism in humans. 
MATERIALS AND METHODS 
Chemicals 
[11,12(N) -3H]all-trans-retinol (TRK 646:60 Ci/mmol) was obtained 
from the Radiochemical Centre, Amersham, U.K. Unlabeled all -trans-
retinol and retinyl acetate were purchased from Sigma, St. Louis, 
Missouri. 3-Dehydroretinol, Ro 22-5356 and 5,6-epoxy-retinoic acid 
were generous gifts from Hoffmann-La Roche Inc . 
The following retinoids we re synthesized in t he laboratory: (i) 4-
0H-retinol by LiAlH4 treatment of Ro 22-5356 [14]; (ii) 5,6-epoxy-
retinol by LiAlH4 treatment of 5,6-expoxy-retinoic acid [15]; (iii) retro-
retinol (rehydro vitamin A) by alkaline hydrolysis of retroretinyl ace-
tate prepared from retinyl acetate as described by Beutel eta! [16]; (iv) 
anhydroretinol (anhydrovitamin A,) and anhydro-3-dehydroretinol 
(anhydrovitamin A2) by treatment of the corresponding a lcohols with 
HCI [14) . 
Human RBP, prealbumin, and serum albumin were from the same 
sources as reported in a previous publication [12]. ["H]Retinol was 
introduced into RBP as described earlier (12]. Dulbecco's modification 
of Eagle's medium (Flow Lab, Ayrshire, U.K.) was used without serum 
supplementation. Additions to the medium were the same as earlier 
[12]. Other chemicals used were of highest available quality. 
Incubation Procedure 
Sheets (0.3 mm) of tissue from human breast skin, obtained in 
connection with plastic surgery, were prepared by means of a Castro-
viejo keratome (Stortz Instrument Co., St Louis, Missouri). The tissue 
sheets (mainly composed of epidermis) were used as such or heat-
inactivated (54"C for 40 s) prior to organ culture on porous membranes 
as described previously [12] . ["H]Retinol-RBP and prealbumin were 
added to the medium at final concentrations of 1 11M and 3 J1M, 
respectively [1 2]. The incubations were terminated by soaking the 
samples (20-25 mg) in cold saline followed by storage at -7o· c under 
ni t rogen until processed. 
High-Performance Liquid Chromatography (HPLC) and Radioactivity 
Measurements of Retinoids 
The skin samples were hydrolyzed in ethanol ic-KOH and extracted 
with hexane after adding carrier retinoids. In some experiments (see 
Results), hydrolysis was omitted and the samples were mechanically 
homogen ized, lyophilized, and extracted with CHC13/CH30H as de-
scribed by Ito et al [17]. Extracts were evaporated and analyzed by 
HPLC as described previously [1] . Reverse-phase chromatography was 
performed on a Nucleosil 5 11M PEAB-ODS column (5 x 200 mm) 
eluted with 20% H 20 in acetonitrile at a flow rate of 1.0 ml/min. 
Fractions (1 ml) were collected and assayed for UV absorption (Lambda 
3, Perkin-Elmer, Oak Brook, Illinois) and radioactivity (P4700, Philips, 
Eindhoven, The Netherlands). Liquid scintillation counting was per-
formed after mixing aliquots of the fractions with Emulsifier-Scintil-
lator 299 (Packard lnstr. Co., Downers Grove, Illinois). The 3H values 
were corrected for losses during analysis. The protein content of the 
extracted samples was determined by a biuret technique [7]. 
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RESULTS 
The incubation of (3H)retinol-RBP with human skin (pre-
dominantly epidermis) resulted in several retinoid metabolites, 
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s h own by HPLC to be more polar than the parent compound 
(Fig lA ). A metabolite elut ing from the column at 12 min 
co migrated with an aut hent ic sample of 3-dehydroretinol. The 
low yield of radioactive retinoids in this experiment prevented 
fur ther characterization of t his metaboli te. In subsequent ex-
periments the incubated samples were hydrolyzed, t hereby 
con verting t he retinoid esters into their free congeners. Neut ral 
r etinoids were recovered in the extract. Fig 1B shows t he HP LC 
r a dioactivity patterns obtained from extracts of normal and 
heat- inactivated skin incubated as before. The yield of radio-
active retinoids was markedly increased by t he hydrolysis. 
Evidently the metabolite comigrating with 3-dehydroretinol 
was not produced by heat-inactivated skin. In both experiments 
more t han 99% of t he radioactivity in the medium migrated as 
a ll- trans- retinol (resul ts not shown) . 
The fractions corresponding to the radioactivity peak at 12 
min (Fig 1B) were collected and subjected to further purifica-
t io n by H PLC. When rechromatographed wit h authent ic reti-
noid standards, a homogeneous peak of radioactivity was ob-
served that coeluted wit h 3-dehydroretinol (Fig 2). Similarly, 
t h e elution pattern of the unknown radioactivity peak, when 
s u bjected to normal-phase HPLC on silica gel in hex-
a n e:ethylacetate (85:15), was ident ical to that for 3-dehydro-
retinol (resul t not shown) . 
A port ion of t he metabolite was mixed wit h 3-dehydroretinol 
a nd exposed to HCl in ethanol to produce t he anhydroform of 
t h e vitamin. Fig 3 shows that, after the HCI treatment, 85% of 
t h e radioactivity migrated together with anhydrovitamin A2 
t hus behaving similarly to authent ic 3-dehydroretinol. 
T able I shows the "H activity in the HP LC fractions corre-
sponding to retinol and 3-dehydroretinol for samples incubated 
under various condit ions. When t he incubations were termi-
n ated after 24 h without subsequent incubation in a t racer- free 
medium, the 3-dehydroretinol activity amounted to 7% of the 
retinol activity. When, on the other hand, t he samples were 
p ostincubated for 22- 26 h in the t racer-free medium, the 3-
d e h ydroretinol activity increased while the retinol activity di-
m inished. As a result the activity of the former amounted to 
18-25% of the latter. 
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F IG 1. HP LC of radioactive vitamin A compounds in human skin 
incu bated fo r 24 h with (3H]retinol-RBP followed by 26 h in a medium 
devoid of t racer. T hree different experiments with similar amounts of 
tissue (1.5- 2.5 mg protein in each) a re shown. A, Extraction wi th 
CHCI:, afte r mechanical homogenization and lyophilization. B, Extrac-
tion wit h hexane afte r KOH hydrolysis- normal skin (.__.) and 
h e at-treated sk in (0 --0). Analysis was performed on a Nucleosil 5 I' 
ODS-column elu ted with water:acetonitrile 20:80 at a fl ow rate of 1.0 
rnl/min . Fractions (1 ml) were collected and moni to red fo r "H activity. 
T h e numbers refe r to elut ion posit ions for (1) 4-0H -retinol; (2) 5,6-
epoxy- retinol; (3) 3-dehydroretinol; (4) retroretinol, and (5) all-trans-
retinol. 
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FIG 2. Peak emerging at 12 min (Fig lB) rechromatographed with 
5 authentic standards. H P LC condit ions and identities of standards 
are the same as in Fig 1. 
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FIG 3. Anhydro derivatization of t he radioactive metaboli te. T he 
principle reaction is shown in t he head. Synthetic 3-dehydroretinol and 
aliquots of t he radioactive material purified by HPLC (Fig 2) were 
t reated with ethanolic HCl an d extracted with hexane after neutrali-
zation [14]. HPLC cond itions as in Fig 1. Numbers refer to (3) 3-
dehydroretinol; (5) all -trans- retinol ; (6) anhydrovitamin A2 ; (7) anhy-
drovitamin A,. 
DISCUSSION 
The conversion of retinol to 3-dehydroretinol in vit ro by 
superficial sheets of human skin offers an explanation for the 
occurrence of the latter compound in epidermis but not in 
plasma [7]. 3- [3H]Dehydroretinol was ident ified by its comigra-
tion wit h aut hentic 3-dehydroretinol in two different HPLC 
systems and by its conversion to anhydrovitamin A2 after HCl 
treatment . By t hese cri teria, 3-dehydroretinol can be distin-
gu ished from all other metabolites of vitamin A. For example, 
retroretinol, which is produced by rat liver (18] and possibly by 
t ransformed mouse fibroblasts [19], elutes slight ly beyond 3-
dehydroretinol at HP LC and is not converted to the anhydro 
form by t reatment wit h HCl (unpublished observation) [18]. 
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TABLE 1.. Epidermal 3H activities at various times of postincubation in 
a. medium devoid of tracer 
Poslincubation Retinol 3-Dehydroretinol 3-Dehydrorelinol 
t ime (h) (cpm/mg protein) (retinol ratio) 
0 9488 625 0.07 
22 7314 1345 0.18 
26 6039 1526 0.25 
The skin samples were first incubated for 24 h with [3H]retinol-RBP 
(1 JLM) and then postincubated for 0- 26 h in a tracer-free medium. 
Extracts of the washed samples were prepared and subjected to HPLC 
as in Fig lB. The radioactivity peaks corresponding to 3-dehydroretinol 
and retinol were collected and the activities related to the protein 
content of the extracted sample after compensating for incomplete 
recoveries. 
Although 3-['1H]dehydroretinol was isolated from incubated 
skin after hydrolysis (Fig 1B), small amounts of a compound 
with properties similar to 3-[3H]dehydroretinol were also found 
after extraction without hydrolysis (Fig 1A ). Previous studies 
have shown that 3-dehydroretinol is not an artifact formed 
during alkaline hydrolysis of the skin [1]. Preliminary results 
show that fatty acyl esters of 3-[3H]dehydroretinol represent a 
major fraction of the metabolite (Torma, Vahlquist, to be 
published) thus explaining the low yield of 3-[3H]dehydrore-
tinol when hydrolysis is omitted. Similar findings have been 
reported for epidermal retinol [20]. 
The production of 3-[3H]dehydroretinol from [3H]retinol in-
creased progressively, even when the tracer was removed from 
the medium, for 22- 26 h after the initial incubation period 
(Table 1) . At the end of the experiment, the proportions of 3-
[3H]dehydroretinol and [3H]retinol were similar to those oc-
curring in vivo [7]. The metabolite, which was not observed in 
the medium, is unlikely to have been produced by the small 
amounts of dermis included in the sample. Epidermis has a 
much higher affinity for [3H]retinol [12] and contains 3-4 times 
more endogenous 3-dehydroretinol than dermis [7]. 
The enzyme(s) mediating the conversion of retinol to 3-
dehydroretinol appears to be heat-labile since pretreatment of 
the skin at 54 oc for 40 s completely inhibited the formation of 
3-['1H]dehydroretinol. By contrast, the uptake of [3H]retinol 
from RBP was unaffected by this treatment, thus corroborating 
previous findings [7]. Further studies on the conversion of 
retinol to 3-dehydroretinol at the subcellular level will hopefully 
shed light on the mechanism behind the increased 3-dehydro-
retinol levels in diseased epidermis [3- 6] and the decreased 
levels after isotretinoin treatment (Rollman and Vahlquist, to 
be published). 
Acidic metabolites of vitamin A were not investigated in this 
report. The biologic significance of the radioactive compound 
comigrating with 5,6-epoxy-retinol during HPLC of the neutral 
retinoids from hydrolyzed skin (Fig 1b) has not been unraveled. 
The compound was also formed after heat inactivation. Human 
epidermis lacks detectable amounts of an endogenous counter-
part [1]. 
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In conclusion, the following sequence of reactions has been 
demonstrated in this work: 
EPIDERMIS 
... :~I apo-RB~ ~cH20H ~ ~cH2oH 
all-trana retinol 3 -dehydroretlnol 
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